Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025

Internationally experienced finance expert to succeed Dr. Bernd Metzner

Duesseldorf, August 29, 2025. The Supervisory Board of Gerresheimer AG has appointed Wolf Lehmann as Chief Financial Officer (CFO). He will succeed Dr. Bernd Metzner on September 1, 2025, who is leaving Gerresheimer at his own request on August 31, 2025, to pursue a new professional challenge. Wolf Lehmann was most recently Operating Partner at private equity firm Triton and has around 30 years of international management experience in finance, strategy, and corporate development in various industries, including transportation, chemicals, industrial services, packaging, and pharmaceuticals. The Industrial Engineering and Business Administration graduate began his career at General Electric (GE), where he first completed the international leadership programs for Financial Management (FMP) and Corporate Audit Staff (CAS) and then served as finance manager in the Propulsion and Specialty Services division at GE Transportation. At GE Silicones, now Momentive Performance Materials, he then took on CFO responsibilities, initially in Germany for the Europe, Middle East, Africa, and India (EMEAI) regions, then in China for the Asia-Pacific region, and subsequently as Global CFO and Vice President Finance in the USA. Further career milestones for the experienced CFO included Wilsonart International and BEFESA. At BEFESA, a Triton portfolio company, he served as Global Chief Financial Officer, overseeing the company's IPO and its uplisting to the MDAX of the Frankfurt Stock Exchange.

“With Wolf Lehmann, Gerresheimer gains an internationally experienced finance expert with extensive operational experience and a proven track record in various industries and regions,” said Dr. Axel Herberg, Chairman of the Supervisory Board of Gerresheimer AG. “He is highly qualified to successfully support Gerresheimer's planned further growth with his financial expertise.”

Dr. Bernd Metzner leaves Gerresheimer at his own request

Wolf Lehmann succeeds Dr. Bernd Metzner, who is leaving Gerresheimer at his own request on August 31, 2025, after six years as CFO to pursue a new professional challenge.

“We accept Dr. Bernd Metzner's wish to terminate his contract early in order to take on a new professional challenge. We would like to thank him for his commitment and achievements over the past six years,” concluded Dr. Axel Herberg.

Given the changes in the Management Board from Dr. Bernd Metzner to Wolf Lehmann in the CFO position as of September 1, 2025, and from Dr. Lukas Burkhardt to Achim Schalk as a member of the Management Board as of November 1, 2025, Gerresheimer will postpone the Capital Markets Day originally planned for October 15, 2025, to a later date.

About Gerresheimer 
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma, the Group generated revenues of around EUR 2.4bn in 2024 and currently employs around 13,600 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).    
www.gerresheimer.com 

Contact Gerresheimer AG